SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-036894
Filing Date
2019-10-15
Accepted
2019-10-15 06:45:31
Documents
30
Period of Report
2019-10-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K MOXIE PART 2 DATA reta-8k_20191014.htm   iXBRL 8-K 41447
2 EX-99.1_PR reta-ex991_6.htm EX-99.1 31666
3 EX-99.2 reta-ex992_69.htm EX-99.2 18023
4 GRAPHIC gjdd1wtq3kvw000012.jpg GRAPHIC 224349
5 GRAPHIC gjdd1wtq3kvw000005.jpg GRAPHIC 183440
6 GRAPHIC gh1cc0g5hy1r000001.jpg GRAPHIC 6766
7 GRAPHIC gjdd1wtq3kvw000008.jpg GRAPHIC 199924
8 GRAPHIC gjdd1wtq3kvw000002.jpg GRAPHIC 548440
9 GRAPHIC gjdd1wtq3kvw000003.jpg GRAPHIC 243459
10 GRAPHIC gjdd1wtq3kvw000004.jpg GRAPHIC 156148
11 GRAPHIC gjdd1wtq3kvw000015.jpg GRAPHIC 118970
12 GRAPHIC gjdd1wtq3kvw000010.jpg GRAPHIC 197953
13 GRAPHIC gjdd1wtq3kvw000014.jpg GRAPHIC 280629
14 GRAPHIC gjdd1wtq3kvw000007.jpg GRAPHIC 212137
15 GRAPHIC gjdd1wtq3kvw000001.jpg GRAPHIC 164278
16 GRAPHIC gjdd1wtq3kvw000009.jpg GRAPHIC 139163
17 GRAPHIC gjdd1wtq3kvw000006.jpg GRAPHIC 161079
18 GRAPHIC gjdd1wtq3kvw000013.jpg GRAPHIC 167445
19 GRAPHIC gjdd1wtq3kvw000011.jpg GRAPHIC 269158
  Complete submission text file 0001564590-19-036894.txt   4752569

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA reta-20191014.xsd EX-101.SCH 5964
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20191014_lab.xml EX-101.LAB 20242
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20191014_pre.xml EX-101.PRE 12081
32 EXTRACTED XBRL INSTANCE DOCUMENT reta-8k_20191014_htm.xml XML 3690
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 191149041
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences